We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

STRR:NASDAQStar Equity Holdings, Inc. Analysis

Data as of 2026-05-03 - not real-time

$9.50

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Star Equity Holdings trades around $9.5, comfortably above its near‑term support of $9.10 but still below the 20‑day SMA of $9.61 and the 50‑day SMA of $9.77, indicating a bearish price bias. The RSI sits near 46, suggesting neither overbought nor oversold conditions, while the MACD histogram has turned positive despite a still‑negative MACD line, hinting at a tentative technical rebound. Volume is declining and the 30‑day volatility is exceptionally high at over 45%, underscoring liquidity and price swing concerns. Fundamentally, the stock appears cheap – a forward PE of ~7 versus an industry average of 31 and a P/B of 0.54 – yet it posts negative profit margins, negative cash flow, and a modest debt‑to‑equity ratio of about 40%, raising questions about sustainability. The consensus price target implies roughly 92% upside, and recent earnings estimate upgrades could provide a catalyst, but the lack of dividend and ongoing operational losses temper enthusiasm. Overall, the technical picture is mixed, the valuation is attractive on multiples, but the financial health and liquidity risks remain pronounced.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price near support but below short‑term moving averages
  • High short‑term volatility and decreasing volume
  • Positive MACD histogram suggesting limited upside

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Significant upside potential implied by consensus price target
  • Attractive valuation multiples relative to industry peers
  • Forward EPS turning positive despite current losses

Long Term

> 3 years
Neutral
Model confidence: 5/10

Key Factors

  • Persistent negative cash flow and operating margins
  • Moderate debt load with limited cash reserves
  • Diversified but still sector‑sensitive industrial conglomerate exposure

Key Metrics & Analysis

Financial Health

Revenue Growth69.00%
Profit Margin-3.44%
P/E Ratio7.3
ROE-11.15%
ROA-1.57%
Debt/Equity40.21
P/B Ratio0.5
Op. Cash Flow$-7255000
Free Cash Flow$-14649125
Industry P/E31.2

Technical Analysis

TrendBearish
RSI45.7
Support$9.10
Resistance$10.31
MA 20$9.61
MA 50$9.77
MA 200$10.13
MACDBullish
VolumeDecreasing
Fear & Greed Index91.09

Valuation

Target Price$19.00
Upside/Downside100.00%
GradeUndervalued
TypeValue

Risk Assessment

Beta0.27
Volatility45.30%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskHigh

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.